INS and Insulin resistance: In consequence of elevated expression levels of PHLPPs reported in insulin target tissues (subcutaneous adipose tissue, skeletal muscle, myotubes) of T2D and obese patients [128,129], and experimentally associated to an insulin resistance status, PHLPPs have been considered as potential therapeutic targets of for insulin resistance treatment [130].